PACS Group Boosts 2026 Outlook as 1Q Tops Views

Dow Jones05-12 20:47
 

By Adriano Marchese

 

Shares in PACS Group rose in premarket trading Tuesday after raising its full-year earnings outlook following a stronger-than-expected first quarter.

Shares rose 18% in premarket trading to C$37.50.

The healthcare company late Monday said it now expects adjusted earnings before interest, taxes, depreciation and amortization of between $605 million and $625 million, up from a previous guidance of $555 million to $575 million.

Analysts polled on FactSet expected $567.2 million.

At the midpoint, the new guidance represents a 22% growth over 2025.

Revenue guidance is maintained at $5.65 billion to $5.75 billion.

PACS noted that the guidance doesn't include any future acquisition, but Chief Executive Carey Hendrickson said that the company has a healthy pipeline of acquisition opportunities that it is actively considering.

For the first quarter, revenue rose 11% to $1.42 billion, topping Wall Street expectations of C$1.36 billion, according to FactSet.

Net income rose to C$80.7 million from C$28.4 million a year earlier, which on a per-share basis was a rise to 50 cents from 17 cents.

Analysts were expecting 40 cents a share.

Hendrickson credits the quarter's results to a strong performance from both newer and existing facilities, as well as improving patient mix.

 

Write to Adriano Marchese at adriano.marchese@wsj.com

 

(END) Dow Jones Newswires

May 12, 2026 08:47 ET (12:47 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment